Sanofi Genzyme is the specialty care global business unit of Sanofi, focused on rare diseases, multiple sclerosis, immunology, and oncology. They help people with debilitating and complex conditions that are often difficult to diagnose and treat. They are dedicated to discovering and advancing new therapies, providing hope to patients and their families around the world. Genzyme became part of Sanofi in 2011. While continuing to focus on rare diseases, they also established ourselves as a leader in the field of multiple sclerosis. In 2016, their focus expanded to include Sanofi’s programs in oncology and immunology. Their approach is shaped by a long history of developing highly specialized treatments and forging close relationships with physician and patient communities. Founded as Genzyme in Boston in 1981, they rapidly grew to become one of the world’s leading biotechnology companies, recognized for their pioneering development of treatments for rare genetic disorders and their innovative contributions to medical science and biomanufacturing.

ONO Pharmaceutical is focused on the production, purchase, and sale of pharmaceuticals and diagnostic reagents on prescription pharmaceuticals. The company focuses on drug discovery leads that are high in certainty and globally competitive. The company was started in 1717 in Dosho-machi, Osaka. Throughout its 300-year history, ONO has dedicated itself to developing innovative and breakthrough pharmaceutical products.

CYBERDYNE Inc. is a venture firm which is established by Dr. Yoshiyuki Sankai, University of Tsukuba, Japan, in order to materialize his idea to utilize Robot Suit HAL® for the benefits of humankind in the field of medicine, caregiving, welfare, labor, heavy works, entertainment and so on. Robot Suit HAL® was developed with the technologies created in Sankai Laboratory of Tsukuba University as an application of “Cybernics*” advocated by Prof. Sankai.

Neurodan A/S develops and commercializes sensory and motor-neuro stimulation medical devices. It manufactures medical implantable devices which restore functionality to patients with central nerve damage through the application of Functional Electrical Stimulation (FES) and Neuro-Muscular Electrical Stimulation (NMES). The company was founded by Thomas Sinkjær and Morten Haugland in 1994 and is headquartered in Aalborg, Denmark.

Provides water treatment services; manufactures and distributes industrial equipment, electronic components, and air-conditioning equipment; generates electricity

Shanghai Hyatt Intelligent Technology Co., Ltd., established on 2018-08-07, The scope of business includes the development of artificial intelligence industry application systems,Transfer of self-owned research and development results and provide relevant technical consultation and technical services;computer software design,to develop,make,Sell ​​self-produced products;Information Technology Consulting;Integrated design of computer systems,Install,debugging,maintain,Intelligent control system integration;Automation control equipment,First,two,Class III Medical Devices(Medical device management),Equipment,Electronic equipment,Wholesale of communication equipment and accessories,commission agent(except auction),Import and export and provide related supporting services.In the field of medical technology(human stem cells,Except for the development and application of genetic diagnosis and treatment technology)technology development,technology transfer,And provide relevant technical advice and technical services.[Items subject to approval by law,Business activities can only be carried out after approval by relevant departments]

Michi Co. Ltd. engages in the production and sale of nail chips. It conducts its business through the e-commerce site michi nail. The company was founded by Shun Nakazaki on June 25, 2012 and is headquartered in Tokyo, Japan.

Novartis AG is a holding company, which engages in the development, manufacture, and marketing of healthcare products. It operates through the following segments: Innovative Medicines, Sandoz, and Corporate. The Innovative Medicines segment researches, develops, manufactures, distributes and sells patented pharmaceuticals, and is composed of two business units: Novartis Oncology and Novartis Pharmaceuticals. The Sandoz segment develops, manufactures and markets finished dosage form medicines as well as intermediary products, including active pharmaceutical ingredients. The Corporate segment refers to group management and central services. The company was founded on February 29, 1996 and is headquartered in Basel, Switzerland.

Paramount Bed Co., Ltd. is engages in the manufacture and distribution of medical and nursing-care products. The firm specializes in the production of beds for medical use, mattresses, bedside items and tools such as walking aids, I.V. stands and rehab tables. The company also operates various businesses in the fields of acute-care; long-term care and residential- and nursing-care; sound sleep and wellness; and maintenance. Paramount Bed was founded in May 1947 and is headquartered in Tokyo, Japan.

De Oro Devices, Inc. is a company headquartered in San Luis Obispo, CA, that develops wearable medical devices. It was founded by Sidney Collin and William Thompson. Sidney Collin is currently the CEO of the firm.

Zhor-Tech is a recognized expert in connected footwear. The company notably created the first ever connected insole (designed for sister company Digitsole) and the first ever smartshoe (introduced at CES '16) With a unique expertise in footwear, biomechanics and electronics, they are able to develop seamless and reliable wearable technology with true user benefit for both users and footwear brands. Zhor-Tech is the technology power-house of footwear brands and can deliver technology as an OEM or as accessories (insoles). Zhor-Tech currently works with some of the largest international footwear brands.

The Kobayashi Pharmaceutical Group provides a variety of products in fields such as pharmaceuticals, fragrances, dietary supplements and daily necessities. Providing products in these diverse fields is a business activity based on the broader management philosophy of “Providing Great Pleasure to People and Society” regardless of the current business domain. The current management philosophy was newly created in April 1999 by adding the meanings of “creation and innovation” and “Something New Something Different”, which are one of the characteristics of the Kobayashi Pharmaceutical Group, to the conventional management philosophy. is. The Kobayashi Pharmaceutical Group believes that pursuing the provision of “Pleasure” for people and society in this management philosophy is the significance of the Kobayashi Pharmaceutical Group.

NEC Corp. engages in the provision of systems, components, services, and integrated solutions for computing and communications applications. It operates through the following segments: Public Business, Enterprise Business, Telecom Carrier Business, System Platform Business, and Others. The Public Business segment provides system integration (system architecture and consulting), support (maintenance), outsourcing and cloud services, and system equipment for public, medical and financial institutions. The Enterprise Business segment offers information technology solutions for manufacturing, retail, and services. The Telecom Carrier Business segment supplies equipment to telecom carriers for network implementation, along with network control platform systems and operating services. The System Platform Business deals with products from business such as from terminals to network and computer equipment, software products, and service platforms. The Others segment includes smart energy solutions, mobile phones, and lighting equipment businesses. The company was founded by Kunihiko Iwadare on July 17, 1899 and is headquartered in Tokyo, Japan.

Korea Institute of Industrial Technology is a South Korean private company that operates as research institute.